<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01049919</url>
  </required_header>
  <id_info>
    <org_study_id>BB-IDE 13996</org_study_id>
    <secondary_id>BBIO.CR.CT002</secondary_id>
    <nct_id>NCT01049919</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)</brief_title>
  <acronym>MOBILE</acronym>
  <official_title>MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will evaluate the safety and efficacy of concentrated bone marrow aspirate (cBMA)
      to prevent or delay major amputation and/or death in subjects with critical limb ischemia
      (CLI) due to severe peripheral arterial disease (PAD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, double-blind, placebo controlled, multicenter trial
      intended for subjects with critical limb ischemia (CLI) that are unsuitable for
      revascularization. The investigational treatment utilizes autologous concentrated bone marrow
      aspirate (cBMA) at the point of care. The bone marrow aspirate is obtained from the subject's
      hip, concentrated with a bone marrow concentration device, and delivered intramuscularly to
      the affected limb. Subjects meeting the inclusion/exclusion criteria will be randomized to
      receive either the investigational treatment (cBMA) or a placebo control (sham treatment).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to treatment failure</measure>
    <time_frame>52 weeks</time_frame>
    <description>&quot;Treatment failure&quot; defined as the composite of major amputation of the index limb or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perfusion and quality of life measurements</measure>
    <time_frame>Throughout 52 week follow-up</time_frame>
    <description>ABI, TBI, rest pain, 6 Minute Walk Test, VascuQol, minor amputations, time to major amputation of the index limb, time to death</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Long-term treatment failure</measure>
    <time_frame>5 years</time_frame>
    <description>Evaluations of long-term amputation-free survival will be assessed for a period of 5 years.</description>
  </other_outcome>
  <other_outcome>
    <measure>Long-term perfusion and quality of life measurements</measure>
    <time_frame>3 years</time_frame>
    <description>ABI, TBI, rest pain, 6 Minute Walk Test, VascuQol, SF-36, wound assessment, minor amputations, time to major amputation of the index limb, time to death</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Critical Limb Ischemia</condition>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Peripheral Vascular Disease</condition>
  <arm_group>
    <arm_group_label>Concentrated bone marrow aspirate (cBMA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Collection of autologous bone marrow aspirate and point-of-care concentration using the bone marrow concentration device, followed by intramuscular injection of concentrated bone marrow aspirate (cBMA) into the affected limb</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo control (sham)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Placebo procedure (sham) consists of simulated bone marrow aspiration followed by simulated intramuscular injections into the affected limb</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bone marrow concentration device</intervention_name>
    <description>Concentration of autologous bone marrow aspirate for intramuscular delivery to affected limb</description>
    <arm_group_label>Concentrated bone marrow aspirate (cBMA)</arm_group_label>
    <other_name>Bone marrow concentrate</other_name>
    <other_name>Bone marrow mononuclear cells</other_name>
    <other_name>MarrowStim</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo procedure (sham)</intervention_name>
    <description>Sham bone marrow aspiration, sham delivery to affected limb</description>
    <arm_group_label>Placebo control (sham)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unilateral or bilateral lower extremity ischemia due to advanced peripheral arterial
             disease

          -  Unsuitable for revascularization

          -  Minor tissue loss (Rutherford Category 5) or ischemic rest pain (Rutherford Category
             4) with ABI ≤ 0.6, or TBI ≤ 0.4, or TcPO2 ≤ 50 mm Hg

          -  Competent to give consent

          -  No current malignancy or history of previous malignancy within the last five years,
             with the exception of adequately treated non-melanoma skin cancer (evidence of
             standard preventative cancer screenings required)

        Exclusion Criteria:

          -  Major tissue loss (Rutherford Category 6)

          -  Diabetics on oral or insulin therapy with uncontrolled or untreated proliferative
             retinopathy (evidence of retinal exam required)

          -  Poorly controlled diabetes mellitus with HbA1C &gt; 10% (evidence of HbA1C test required)

          -  Uncompensated congestive heart failure (New York Heart Association Class IV) and/or
             other conditions that preclude general anesthesia

          -  Myocardial infarction or stroke within last 90 days

          -  Elevated liver function tests (AST or ALT more than twice normal upper limit)

          -  Renal disease (creatinine &gt; 2.5 mg/dl) or chronic hemodialysis

          -  White blood cell count &lt; 3,000/µL or &gt; 15,000/µL, platelet count &lt; 100,000/µL, or
             hematocrit &lt; 32%

          -  Topical growth hormone therapy within last 90 days, or injected growth hormone therapy
             within last 180 days

          -  Disease of central nervous system and/or other conditions that impair cognitive
             function

          -  Two or more episodes of pulmonary embolus with a documented DVT in index leg or
             history of DVT in index leg without evidence of clot resolution

          -  Current infection of index leg

          -  Pregnant women (negative urine pregnancy test required)

          -  Lower extremity venous disease with pitting edema in index leg

          -  Recent history (in the 6 months prior to screening) of bone marrow disease or
             treatment with any medication or procedure which adversely affects the bone marrow and
             would prohibit transplantation

          -  Current osteomyelitis in index leg

          -  Existing HIV diagnosis

          -  Organ transplant recipients

          -  Known terminal disease process with life expectancy less than one year

          -  Severe concomitant disease(s) or any additional condition(s) which the investigator
             feels constitute(s) criteria for exclusion of a particular subject

          -  Major amputation required within 30 days

          -  Inclusion in any other clinical study that may affect the outcome of this study

          -  Uncorrected stenosis(es) of greater than 50% in the common and/or external iliac
             artery and/or common femoral artery of the index leg.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael P. Murphy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Arkansas Veterans Healthcare System</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California-Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medstar Health Research Institute</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Illinois University</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tuft's Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Health Care</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nebraska-Western Iowa VA Healthcare System</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Name Medical Center</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College / New York-Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Remington-Davis</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Pittsburgh Healthcare System</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Hospital</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Sacred Heart Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.padstudy.org</url>
    <description>Click here for more information about the MOBILE Study</description>
  </link>
  <reference>
    <citation>Murphy MP, Lawson JH, Rapp BM, Dalsing MC, Klein J, Wilson MG, Hutchins GD, March KL. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg. 2011 Jun;53(6):1565-74.e1. doi: 10.1016/j.jvs.2011.01.074. Epub 2011 Apr 22.</citation>
    <PMID>21514773</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2010</study_first_submitted>
  <study_first_submitted_qc>January 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2010</study_first_posted>
  <disposition_first_submitted>June 19, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>June 19, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">June 23, 2017</disposition_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critical Limb Ischemia</keyword>
  <keyword>Peripheral Arterial Disease</keyword>
  <keyword>Peripheral Vascular Disease</keyword>
  <keyword>CLI</keyword>
  <keyword>PAD</keyword>
  <keyword>PVD</keyword>
  <keyword>Angiogenesis</keyword>
  <keyword>Stem Cells</keyword>
  <keyword>Cell Therapy</keyword>
  <keyword>Limb Salvage</keyword>
  <keyword>Amputation</keyword>
  <keyword>Leg Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

